Daily Roundup

FOS Capital Ltd kicked off the new financial year on a strong note, reporting Q1 FY27 sales of $7.25 million—a impressive 64% jump year-over-year. The company also swung to profitability with EBITDA of $0.55 million, a significant turnaround from prior periods. Behind these numbers sits a healthy order book of $10.5 million, up 15% annually, and an active quote pipeline sitting at a robust $130 million. The company recently locked in major wins including the Monash Medical Clinic project and the Queensland Schools Lighting Upgrade Program, while also completing a $1.82 million capital raise. Management expects the momentum to carry through Q2, with sales volumes anticipated to track similarly to the first quarter.

Insurance Australia Group (IAG) is making moves to smooth its merger with the Royal Automobile Club of Western Australia through the ACCC review process. The insurer has sweetened its offer with several commitments designed to address regulatory concerns. Most notably, IAG will transfer NRMA Insurance renewal rights for home and motor policies in Western Australia to a competing insurer, invest $20 million in community resilience initiatives across the state over the next decade, and tackle the limited insurance availability issue in northern regions. The company expects these concessions to unlock substantial public benefits, including enhanced claims handling, better disaster response capacity, and improved technology access. IAG remains confident the deal will be earnings accretive in its first full year of ownership.

Locality Planning Energy Holdings Ltd (LPE) delivered a stellar FY26 performance that signals real momentum heading into the new year. Net profit surged 166% to $2.31 million, while gross profit margin expanded to 25.0% despite a slight revenue dip. The company also made serious headway on its balance sheet, cutting its debt-to-total-assets ratio down to just 0.5%. Looking ahead, LPE plans to capitalize on its growing service point pipeline through renewals, acquisitions, and new builds—bolstered by recent initiatives like the PowerHub acquisition and fresh partnerships.

Clever Culture Systems Ltd is broadening its reach in the pharmaceutical sector by tapping PSC Biotech Corporation as a sales agent for its APAS® Independence system across the US, Canada, and Singapore. The partnership targets a new tier of customers—regional and mid-sized pharmaceutical manufacturers—complementing CCS's existing direct strategy focused on the world's largest drugmakers. PSC Biotech will hunt for opportunities and earn commissions on hardware sales, while CCS retains control of pricing, software, and service revenue. The company expects this channel to meaningfully expand qualified sales opportunities over the next year, with a notable lift to instrument sales anticipated from FY28 onwards.

SKS Technologies Group Ltd fielded an ASX query about recent trading activity but confirmed there's nothing hidden in the cupboard. The company stated it has no undisclosed information that would explain the recent price movement or trading volume spike, suggesting instead that sector-wide market influences may have played a role. SKS emphasized its compliance with ASX Listing Rules and remains focused on converting its pipeline of opportunities into secured work.